Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Rating) fell 4.5% during trading on Friday . The stock traded as low as $15.06 and last traded at $15.16. 44,219 shares traded hands during trading, a decline of 79% from the average session volume of 205,918 shares. The stock had previously closed at $15.88.
Health Sciences Acquisitions Co. 2 Stock Performance
The company has a 50 day moving average price of $16.95 and a 200 day moving average price of $12.56.
Institutional Trading of Health Sciences Acquisitions Co. 2
Institutional investors have recently added to or reduced their stakes in the company. UBS Group AG boosted its stake in Health Sciences Acquisitions Co. 2 by 468.2% in the 3rd quarter. UBS Group AG now owns 2,824 shares of the company’s stock valued at $28,000 after purchasing an additional 2,327 shares during the period. RPO LLC acquired a new position in Health Sciences Acquisitions Co. 2 in the 3rd quarter valued at $240,000. Spartan Fund Management Inc. acquired a new position in Health Sciences Acquisitions Co. 2 in the 4th quarter valued at $267,000. Goldman Sachs Group Inc. acquired a new position in Health Sciences Acquisitions Co. 2 in the 1st quarter valued at $578,000. Finally, Graham Capital Wealth Management LLC acquired a new position in Health Sciences Acquisitions Co. 2 in the 4th quarter valued at $649,000. 89.71% of the stock is currently owned by institutional investors.
About Health Sciences Acquisitions Co. 2
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe.
Featured Articles
- Get a free copy of the StockNews.com research report on Health Sciences Acquisitions Co. 2 (HSAQ)
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
- Foot Locker And The Ebbing Tide Of Discretionary Spending
Receive News & Ratings for Health Sciences Acquisitions Co. 2 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions Co. 2 and related companies with MarketBeat.com's FREE daily email newsletter.
